Corporate DisclosureSQURPHARMA
SQURPHARMA Corporate Disclosure — 18 February 2020
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 18 February 2020. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
The Company has informed that the Board of Directors has taken the following decisions i) The Company shall establish a virtually wholly owned subsidiary Company in the name and style of "Square Lifesciences Ltd." in order to manufacture pharmaceuticals Oral Solid Dosage products. (cont.)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616aceb25a6b000040057692
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.